Google
Trusted Resources: People & Places
Healthcare providers, researchers, and advocates
Amber Yates, MD
Healthcare Provider Associate Director
Pediatric Hematology-Oncology Fellowship Program
Texas Children's Hospital
6701 Fannin Street
Suite 1580
Houston, Texas, United States
Dr. Amber Yates is an Associate Director of the Pediatric Hematology-Oncology Fellowship Program. She is also Co-Director of the Sickle Cell Program, a member of the Hematology Center and Associate Professor Of Pediatrics at Baylor College of Medicine.
Her primary clinical interest is in the care of children with sickle cell disease and other hemoglobin disorders. She is particularly interested in the role of hydroxyurea therapy in improving the lives of children with sickle cell disease, as well as the long term safety and efficacy of hydroxyurea. Her other clinical interests include: hemoglobinopathies and hemolytic anemia.
Dr. Amber Yates is also interested in assisting teenage patients with hematologic disorders so they can achieve a successful transition to adult care.
Representative Publications:
Hydroxyurea treatment of children with hemoglobin SC disease
+myBinderRelated Content
-
Carlton D. Dampier, MDDr. Carlton Dampier is a pediatric hemat...
-
Sickle cell patients suffer as disparities in care and research persistWhen 9-year-old Jeremy Brown is in pai...
-
Jo Howard, MB BChir, MRCP, FRCPathJo Howard, MB BChir, MRCP, FRCPath, beca...
-
Healthcare Providers and Sickle Cell DiseaseSickle cell disease (SCD) is a group of ...
-
California Institute For Regenerative Medicine Awards City Of Hope $5.74 Million For Severe Sickle Cell Disease Clin...The California Institute for Regenerativ...
-
Adult Sickle Cell Clinic at UAMSThe University of Arkansas for Medical S...
-
SCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
